Book contents
- A Textbook of Clinical Embryology
- A Textbook of Clinical Embryology
- Copyright page
- Contents
- Frontispiece
- Chapter Co-authors
- Acknowledgments
- Section 1 Physiology of Reproduction
- Section 2 Assisted Reproductive Procedures
- Chapter 6 Hormonal Ovarian Treatment
- Chapter 7 Luteal Support
- Chapter 8 Ovum Pickup (OPU)
- Chapter 9 In Vitro Fertilization (IVF)
- Chapter 10 Embryo Culture
- Chapter 11 Embryo Transfer
- Chapter 12 Cryopreservation
- Chapter 13 In Vitro Maturation (IVM)
- Chapter 14 Biopsy of Testicles
- Chapter 15 Donation and Surrogacy
- Section 3 Genetics and Preimplantation Genetic Testing
- Section 4 IVF Laboratory
- Index
- References
Chapter 7 - Luteal Support
from Section 2 - Assisted Reproductive Procedures
Published online by Cambridge University Press: 05 March 2021
Edited by
Book contents
- A Textbook of Clinical Embryology
- A Textbook of Clinical Embryology
- Copyright page
- Contents
- Frontispiece
- Chapter Co-authors
- Acknowledgments
- Section 1 Physiology of Reproduction
- Section 2 Assisted Reproductive Procedures
- Chapter 6 Hormonal Ovarian Treatment
- Chapter 7 Luteal Support
- Chapter 8 Ovum Pickup (OPU)
- Chapter 9 In Vitro Fertilization (IVF)
- Chapter 10 Embryo Culture
- Chapter 11 Embryo Transfer
- Chapter 12 Cryopreservation
- Chapter 13 In Vitro Maturation (IVM)
- Chapter 14 Biopsy of Testicles
- Chapter 15 Donation and Surrogacy
- Section 3 Genetics and Preimplantation Genetic Testing
- Section 4 IVF Laboratory
- Index
- References
Summary
The corpus luteum (CL) is a transitory endocrine gland that develops from the postovulatory ruptured follicle during the luteal phase. Human chorionic gonadotropin (hCG), produced by the embryo, maintains the secretory activity of the CL due to its structural similarity to luteinizing hormone (LH) and subsequent activation of the same receptor. It maintains and stimulates the CL to produce estradiol (E2) and progesterone (P4). Luteal P4 is involved in the transition of the endometrium from a proliferative to a secretory type, with increasing decidualization – an essential facilitator of implantation [1] – and relaxation of the uterine muscle. Preparation of the endometrium lining the uterus for implantation of the embryo begins toward the end of a proliferative phase and extends throughout the luteal phase. This is important for the implantation process and maintenance of pregnancy until the placenta takes over steroid hormone production at approximately 7 weeks.
Information
- Type
- Chapter
- Information
- A Textbook of Clinical Embryology , pp. 85 - 88Publisher: Cambridge University PressPrint publication year: 2021
References
Jabbour, HN, Kelly, RW, Fraser, HM, Critchley, HO. Endocrine regulation of menstruation. Endocr. Rev. 2006; 27:17–46.CrossRefGoogle ScholarPubMed
Garcia, J, Jones, GS, Acosta, AA, Wright, GL. Corpus luteum fuction after follicle aspiration for oocyte retrieval. Fertil. Steril. 1981; 36:565–572.Google Scholar
Fatemi, HM, Popovic-Todorovic, B, Papanikolaou, E, Donoso, P, Devroey, P. An update of luteal phase support in stimulated IVF cycles. Hum. Reprod. Update 2007; 13:581–590.Google Scholar
O’Neill, C, Ferrier, AJ, Vaughan, J, Sinosich, MJ, Saunders, DM. Causes of implantation failure after in-vitro fertilization and embryo transfer. Lancet 1985; 2:615.Google Scholar
The ESHRE Capri Workshop Group. Anovulatory infertility. Hum. Reprod. 1995; 10:1549–1553.CrossRefGoogle Scholar
Duncan, WC. A guide to understanding polycystic ovary syndrome (PCOS). J. Fam. Plann. Reprod. Health Care 2014; 40:217–225.Google Scholar
Mackens, S, Santos-Ribeiro, S, van de Vijver, A, et al. Frozen embryo transfer: a review on the optimal endometrial preparation and timing. Hum. Reprod. 2017; 32:2234–2242.Google Scholar
Kutlusoy, F, Guler, I, Erdem, M, et al. Luteal phase support with estrogen in addition to progesterone increases pregnancy rates in in-vitro fertilization cycles with poor response to gonadotropins. Gynecol. Endocrinol. 2014; 30:363–366.Google Scholar
Ho, CH, Chen, SU, Peng, FS, Chang, CY, Yang, YS. Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone. J. Chin. Med. Assoc. 2008; 71:386–391.CrossRefGoogle ScholarPubMed
Barbosa, MW, Silva, LR, Navarro, PA, et al. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet. Gynecol. 2016; 48:161–170.Google Scholar
Saccone, G, Khalifeh, A, Elimian, A, et al. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis randomized controlled trials. Ultrasound Obstet. Gynecol. 2017; 49:315–321.Google Scholar
Child, T, Leonard, SA, Evans, JS, Lass, A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. RBM Online 2018; 36:630–645.Google Scholar
Tournaye, H, Sukhikh, G, Kuhler, E, Griesinger, G. A phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum. Reprod. 2017; 32:1019–1027.CrossRefGoogle ScholarPubMed
Baker, V, Jones, C, Doody, K, et al. A randomized controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Hum. Reprod. 2014; 29:2210–2220.Google Scholar
Kleinstein, J. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. Fertil. Steril. 2005; 83:1641–1649.Google Scholar
van der Linden, M, Buckingham, K, Farquhar, C, Kremer, JA, Metwally, M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst. Rev. 2015; CD009154. doi:10.1002/14651858.CD009154.CrossRefGoogle Scholar
Hutchison, JS, Zeleznik, AJ. The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support. Endocrinology 1985; 117:1043–1049.Google Scholar
Liu, X, Mu, H, Shi, Q, Xiao, X, Qi, H. The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis. Reprod. Biol. Endocrinol. 2012; 10:107–115.Google Scholar
Thomsen, LH, Kesmodel, US, Erb, K, et al. The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles. Hum. Reprod. 2018; 33:1506–1516. doi:10.1093/humrep/dey226.Google Scholar
Silver, RI. Endocrine abnormalities in boys with hypospadias. Adv. Exp. Med. Biol. 2004; 545:45–72.Google Scholar
Vaisbuch, E, de Ziegler, D, Leong, M, Weissman, A, Shoham, Z. Luteal-phase support in assisted reproduction treatment: real-life practices reported worldwide by an updated website-based survey. RBM Online 2014; 28:330–335.Google Scholar
Accessibility standard: Unknown
Why this information is here
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.Accessibility Information
Accessibility compliance for the HTML of this chapter is currently unknown
and may be updated in the future.